Published in JAMA on October 06, 2004
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion | NCT03999229
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A (2007) 2.77
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med (2012) 2.02
Arterial thrombosis--insidious, unpredictable and deadly. Nat Med (2011) 1.96
Recommendations for the transfusion of red blood cells. Blood Transfus (2009) 1.85
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 1.85
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A (2005) 1.67
Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA (2014) 1.53
Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: methods of reducing patient risk. Crit Care Med (2010) 1.53
Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.53
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus (2011) 1.45
Transcarpal cardiac catheterization. Dtsch Arztebl Int (2009) 1.43
Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J (2013) 1.31
Applying propensity score methods in medical research: pitfalls and prospects. Med Care Res Rev (2010) 1.27
Impaired adenosine-5'-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. Crit Care Med (2011) 1.26
The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res (2009) 1.25
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J (2009) 1.21
Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol (2011) 1.20
Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience. J Cardiothorac Surg (2012) 1.20
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry. J Am Coll Cardiol (2012) 1.17
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.17
S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. J Clin Invest (2013) 1.12
Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ (2008) 1.12
New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion (2011) 1.11
Tangential flow filtration of hemoglobin. Biotechnol Prog (2009) 1.10
Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clin Sci (Lond) (2011) 1.10
Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost (2009) 1.09
Anemia and blood transfusion in a surgical intensive care unit. Crit Care (2010) 1.06
The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J (2012) 1.06
Red blood cell transfusion in the critically ill patient. Ann Intensive Care (2011) 1.04
Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovasc Diabetol (2006) 1.00
Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study. PLoS Med (2014) 0.99
The effect of age and clinical circumstances on the outcome of red blood cell transfusion in critically ill patients. Crit Care (2014) 0.98
Blood transfusion practices: a little consistency please. Blood Transfus (2011) 0.97
Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res (2010) 0.97
Nanobiotechnology for hemoglobin-based blood substitutes. Crit Care Clin (2009) 0.96
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass. J Extra Corpor Technol (2007) 0.94
Treating critical illness: the importance of first doing no harm. PLoS Med (2005) 0.94
Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. CMAJ (2008) 0.93
S-nitrosylation therapy to improve oxygen delivery of banked blood. Proc Natl Acad Sci U S A (2013) 0.92
Do transfusions get to the heart of the matter? JAMA (2004) 0.91
The transfusion problem: role of aberrant S-nitrosylation. Transfusion (2011) 0.91
Impact of erythropoietin on intensive care unit patients. Transfus Med Hemother (2013) 0.91
Anemia and red blood cell transfusion in critically ill cardiac patients. Ann Intensive Care (2014) 0.89
Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty. J Thromb Thrombolysis (2012) 0.89
Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care (2006) 0.89
Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc Health Risk Manag (2012) 0.88
Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfus (2011) 0.88
The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eur Heart J Acute Cardiovasc Care (2013) 0.88
In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol (2011) 0.87
Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart (2014) 0.87
Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. JACC Cardiovasc Interv (2013) 0.85
Mechanisms linking red blood cell disorders and cardiovascular diseases. Biomed Res Int (2015) 0.83
Impact of renal dysfunction on long-term outcomes of elderly patients with acute coronary syndrome: a longitudinal, prospective observational study. BMC Nephrol (2014) 0.83
Effect of irradiation and/or leucocyte filtration on RBC storage lesions. PLoS One (2011) 0.81
Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro. Transfusion (2013) 0.81
The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review. J Extracell Vesicles (2014) 0.81
Red cell physiology and signaling relevant to the critical care setting. Curr Opin Pediatr (2015) 0.80
Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East. Clin Med Res (2012) 0.80
A random forest based risk model for reliable and accurate prediction of receipt of transfusion in patients undergoing percutaneous coronary intervention. PLoS One (2014) 0.80
Anemia in heart failure patients. ISRN Hematol (2012) 0.80
Intraoperative blood transfusion of one or two units of packed red blood cells is associated with a fivefold risk of stroke in patients undergoing elective carotid endarterectomy. J Vasc Surg (2013) 0.80
Research opportunities in optimizing storage of red blood cell products. Transfusion (2013) 0.80
Managing anemia in patients with chronic heart failure: what do we know? Vasc Health Risk Manag (2010) 0.80
Restrictive and liberal red cell transfusion strategies in adult patients: reconciling clinical data with best practice. Crit Care (2015) 0.80
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty. Vasc Health Risk Manag (2012) 0.80
Blood transfusion in patients with acute coronary syndrome. JAMA (2005) 0.79
Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol (2010) 0.79
Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2009) 0.79
1 RBC Concentrates. Transfus Med Hemother (2009) 0.79
Perioperative clopidogrel and postoperative events after hip and knee arthroplasties. Clin Orthop Relat Res (2012) 0.79
Blood transfusion in critical care. F1000 Med Rep (2009) 0.79
Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol (2013) 0.78
Isn't it about time we learned how to use blood transfusion in patients with ischemic heart disease? J Am Coll Cardiol (2013) 0.78
Hemorrhagic shock and nitric oxide release from erythrocytic nitric oxide synthase: a quantitative analysis. Microvasc Res (2009) 0.78
Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention. Vasc Health Risk Manag (2011) 0.78
Systematic Review and Meta-Analysis of Major Cardiovascular Outcomes for Radial Versus Femoral Access in Patients With Acute Coronary Syndrome. South Med J (2016) 0.78
Identification of hospital outliers in bleeding complications after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes (2014) 0.77
Quick biochemical markers for assessment of quality control of intraoperative cell salvage: a prospective observational study. J Cardiothorac Surg (2014) 0.77
The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome. Future Cardiol (2012) 0.77
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis. Ann Intensive Care (2017) 0.77
Anemia and blood transfusions in critically ill patients. J Blood Transfus (2012) 0.76
Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia. J Extracell Vesicles (2015) 0.76
Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic study. J Cardiothorac Surg (2013) 0.76
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm. Can J Cardiol (2006) 0.76
Supra-plasma expanders: the future of treating blood loss and anemia without red cell transfusions? J Infus Nurs (2015) 0.76
Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention. Heart Vessels (2010) 0.75
Clinical review: bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management. Crit Care (2013) 0.75
Antiplatelet agents in clinical practice and their haemorrhagic risk. Blood Transfus (2013) 0.75
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding. Am J Cardiovasc Dis (2011) 0.75
Effect of haemoglobin concentration on the clinical outcomes in patients with acute myocardial infarction and the factors related to haemoglobin. BMC Res Notes (2011) 0.75
Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement. Cardiovasc Drugs Ther (2009) 0.75
Safety of red blood cell substitutes as compared to stored donor red blood cells. Artif Cells Blood Substit Immobil Biotechnol (2008) 0.75
A retrospective study investigating the incidence and predisposing factors of hospital-acquired anemia. Anemia (2014) 0.75
Guidelines-based treatment of anaemic STEMI patients: practice patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. Eur Heart J Acute Cardiovasc Care (2013) 0.75
2008 Emily Cooley Memorial Lecture: lessons learned from pediatric transfusion medicine clinical trials . . . a little child shall lead them. Transfusion (2009) 0.75
A survey of resident physicians' knowledge concerning transfusion medicine in Shiraz, Iran. Asian J Transfus Sci (2014) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Human genetic variation and its contribution to complex traits. Nat Rev Genet (2009) 12.11
Universal definition of myocardial infarction. Circulation (2007) 11.69
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med (2013) 11.14
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 11.06
Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol (2005) 10.65
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
The ClinicalTrials.gov results database--update and key issues. N Engl J Med (2011) 9.83
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol (2009) 9.59
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA (2004) 7.32
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med (2011) 6.90
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet (2003) 6.85
Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev (2009) 6.85
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA (2003) 6.84
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA (2011) 6.39
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature (2011) 6.25
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA (2007) 6.06
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med (2010) 6.05
Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med (2003) 5.89
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA (2006) 5.74
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol (2003) 5.51
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet (2003) 5.34
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet (2004) 5.31
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med (2006) 5.07
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med (2009) 4.83
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol (2009) 4.80
Can mobile health technologies transform health care? JAMA (2013) 4.75
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol (2007) 4.74
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA (2007) 4.59
Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science (2008) 4.51